A Study Evaluating Cadonilimab Injection in Combination With Regorafenib for the Treatment of Biliary Systemic Tumours

PHASE1RecruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

November 25, 2022

Primary Completion Date

November 25, 2025

Study Completion Date

November 25, 2025

Conditions

Advanced Biliary Systemic Tumours That Has Failed at Least One Prior Systemic Therapy

Interventions

DRUG

Cadonilimab Injection

Cadonilimab Injection, 6mg/kg, intravenous drip ,q2w,

DRUG

Regorafenib

Regorafenib 80mg, po, orally once daily

Trial Locations (1)

RECRUITING

Tianjin Cancer Hospital Airport Hospital, Tianjin

All Listed Sponsors

lead

Tianjin Medical University Cancer Institute and Hospital

OTHER